Recently we described a protein, smoothelin, that has been exclusively found in smooth muscle cells (SMC). The humanCDNA has been cloned from a colon CDNA library and the putative protein sequence was deduced. Smoothelin does not belong to a known protein family but shows a partial homology with members of the spectrin family. Transfection studies revealed that smoothelin has an affinity for actin and is either capable of forming filamentous structures or colocalizes with such structures. The protein is expressed in visceral as well as vascular tissues of all vertebrate classes. A study on the distribution of smoothelin in the vascular and placental system showed that smoothelin expression was largely restricted to the muscular pulsating blood vessels. Therefore, we hypothesized that smoothelin is expressed in contractile SMConly (36, 37).
Smooth muscle cells (SMC)are found in those organs that are involved in basic physiological functions such as breathing, reproduction and transport of nutrients and oxygen. Although SMCappear more 'primitive' in organization and differentiation, as compared to striated (cardiac and skeletal) muscle cells, they developed simultaneously during evolution (13, 23) . Skeletal and cardiac muscle are referred to as striated muscle because of their conspicious transverse striations showing the high level of organization of actin and myosin filaments in the myofibers. On the other hand, in SMCactin and myosin filaments have a less ordered organization that has still to be clearly defined. Both striated muscle cell types have a terminal differentiation, i.e. once they become a skeletal or a heart muscle cell they will, under physiological conditions, not return to a previous differentiation stage. In contrary, SMCcan shut-tie between a contractile and a synthetic/proliferative phenotype, a process called modulation (4, 5). During embryogenesis striated muscle cells differentiate and migrate according to well denned developmental pathways whereas the embryological origin of smooth muscle cells appears to be diverse and is still a matter of debate (15, 16) . SMCaligning the digestive and genital tracts appear to be derived from the mesodermal plate whereas SMCof the vascular system are suggested to be recruited from the surroundings of the blood vessels and to differentiate into SMCunder the influence of factors secreted by endothelial cells (38) . One reason for the relatively poor understanding of SMCbiology is the lack of markers indicative for the phenotypes of these cells and/or for their embryological origin. A number of proteins, such as calponin, metavinculin and a-smooth muscle actin, have been suggested as markers for SMC (7, 10, ll, 12, 14, 19, 31, 33) . However, they are also found in other tissues during embryonic development and in certain pathological conditions (1, 2, 3, 22, 25, 34, 35) . The protein that can be qualified as most SMCspecific is the smooth muscle myosin heavy chain isoforms SMI and SM2 (21, 26) .
These proteins are found only in SMC and are expressed relatively late during ontogenesis. As stated by Owens (26) "It is critical to distinguish proteins that are characteristic of a given stage (or state) of SMCdifferentiation/maturation versus proteins that alone can serve as definitive markers for identification of SMClineages to the exclusion of all other cell types". Recently, we described the detection and characterization of a smooth muscle specific protein, smoothelin (36, 37) . We hypothesized that the protein might be specific for the contractile phenotype of SMC.This hypothesis was based on four characteristics of smoothelin.
1) The absence of the protein in cultured SMC.No smoothelin was found in the SMClines and the primary cultures of SMCtested. This might be due to selection (only proliferative SMCwill continue to grow in culture) or to dedifferentiation (contractile SMCrevert to the proliferative SMC).
2) The decline of smoothelin transcription in tissue explants. It was found that smoothelin mRNA disappears within 12 hours after dissection of the smooth muscle tissue (36) .
3) The distribution of smoothelin in the vascular system. The smoothelin content of a variety of blood vessels in adults and during vasculogenesis of the placenta was investigated by immunofluorescence and immunoblotting.
Smoothelin concentrations paralleled the contractility of the vessels (37) . 4) The affinity of smoothelin for actin. Since actin is one of the major componentsof the contractile machinery, the affinity of smoothelin might indicate a function in the contractile apparatus of SMC.
These data suggested that smoothelin is a marker for SMCof the contractile type and as such for the final differentiation stage of SMC.
In this paper we summarize the present knowledge about smoothelin and demonstrate its suitebility as a late differentiation marker, i.e. a marker for SMCof the contractile phenotype. A cell culture system is presented which maintains smoothelin synthesis. In addition, we show that a vascular-specific form of smoothelin occurs. The excistence of the two isoforms may pro- Miles Inc. Elkhart, IN, USA), and 3 to 5 fim thick sections were cut at -25°C and air-dried overnight at room temperature or immediately fixed with methanol (at -20°C for 5 min) followed by acetone (-20°C for 30 sec) and airdried for 3 hours before use. Cultured cells were grownon microscopic cover slips and fixed by shortly dipping in methanol/acetone at -20°C.
Culture of prostate epithelial cells. Fresh transuretherally resected prostatic tissue from benign prostate hyperplasia patients was cut into 1-2mm3 pieces and spread in a 25 cm2 flask. Fragments were allowed to adhere to the plastic substrate and covered with 2ml of 'collection medium'
[Dulbecco's Modified Essential Medium supplemented with 20% fetal calf serum, penicillin (100 U/ml), streptomycin (100 //g/ml) and amphotericin (2.5 //g/ml), all purchased from Life Technologies]. Explants were allowed to settle for at least 96 hours, then mediumwas changed twice a week. Whencells started to migrate out of the tissue fragments 'collection medium'was replaced by 'smooth muscle specific medium' [MDCB-131medium supplemented with 15% horse serum, 10 mMHepes pH 7.2, 2% penicillin/streptomycin, 2%
MEM-Eagle's solution of non-essential amino acids (all Life
Technologies, Gaithesburg, MD), 5^g/ml insulin, 10^g/ml transferrin, 5 ng/ml sodium selenite, 0.1^M estradiol, 0.1 [i% dexamethasone (all from Sigma, St. Louis, MO)]. The 'smooth muscle specific medium' was mixed with conditioned mediumfrom cell line LNCAP at a ratio 3:1. The conditioned LNCAP mediumwas obtained by growing the cells in base medium (MDCB-131, 15% horse serum, 10mM Hepes pH 7.2, 2% MEMEagle's solution of non-essential amino acids) for 3-5 days. Mediumwas separated from the cells by filtration and was stored at 4°C until use. Prostatic cell cultures were maintained in an atmosphere of 5% CO2/95% humidified air. Every 2-3 days the mediumwas replaced. Once the cells had reached con fluency they were trypsinized and transfered to fresh flasks in a 1:5 dilution. Antibodies. Antibodies used in this study were: 1. The mouse monoclonal antibody R4A directed against smoothelin (36 Protein gel electrophoresis and Western blotting. Approximately 40 cryostat sections (each 20 ftm thick) of fresh frozen tissues or about 106 cultured cells were collected, washed with 1 ml PBS and centrifuged for 5 min at 12.000xg. After centrifugation the pellet was subjected to a Triton X-100 extraction step and after a PBS wash suspended in 1%Triton X-100, 5 mMethylene-diamino-tetra-acetic acid disodium salt dihydrate (EDTA; Merck), 0.4 mMphenylmethylsulfonyl fluoride (PMSF; Merck) in PBS, pH 7.4 (36) , and extracted for 5 min on ice. After centrifugation for 5 min at 12.000xg, the pellet was washed in 1 ml PBS. After a final centrifugation step (5 min, 12.000 x g), the cytoskeletal preparation was dissolved by boiling for 4 min in sample buffer (18), containing 2.3% sodium dodecylsulfate (SDS) and 5% /3-mercaptoethanol (Bio-Rad Laboratories, Richmond, CA, USA). For one-dimensional SDS-polyacrylamide gel electrophoresis (SDS-PAGE) using a Mini Protean II Electrophoresis Cell (Bio-Rad Laboratories) 7.5-10% polyacrylamide slab gels containing 0. 1% SDS (18) were used. After electrophoretic separation, the proteins were stained with Page Blue 83 (BDHChemicals Ltd.) or subjected to Western blotting. Culture supernatant of monoclonal antibody R4Adirected against smoothelin was used in a 1 :5 dilution and immunodetection with horseradish peroxidase conjugated rabbit anti-mouse-Ig (DAKOA/S) was performed according to standard procedures. Southern blot analysis. Total nuclear humanDNAwas isolated from peripheral white blood cells by phenol extraction according to standard procedures (30) . DNAwas restric-tion digested and transferred to HiBond (Amersham, UK) (32) . Filters were hybridized with 50-200 ng of smoothelin CDNAprobe labeled with [a-32P]dATP by random priming (9) at a temperature of 60°C (6). Filters were washed at a final stringency of 0.1 SSC/0.1% SDS at 60°C. In situ hybridization. The probe used for chromosome 22 identification has been described by Kurahashi and coworkers (17) . Probe labeling and fluorescent in situ hybridizations (FISH) was carried out as described previously (8). FISH with probe CHKAD-25, specific for chromosome region 22q23-22qter (17) were performed simultaneously with a smoothelin cosmid probe.
RESULTS

Characteristics of the two isoforms of smoothelin.
Sections of different smooth muscle tissues from a number of species were incubated with antibody R4A. SMC of the visceral tissues, the urogenital tract and the vascular system reacted all with monoclonal antibody R4A in immunofluorescence microscopy (Fig. 1) . In all these tissues R4Apositive SMCdisplayed a strong cytoplasmic staining. However, in immunoblotting a clear difference was revealed between visceral/urogenital tissues on the one hand and vascular tissue on the other. The visceral and urogenital tissues contain a smoothelin protein of 59 kDa. The main reactive protein in vascular tissue showed as a 94kDa band in human, pig, rabbit and dog. In addition, in these tissues a faint band was observed at 59 kDa (Fig. 2) . The 'heavy' isoform of smoothelin is unlikely to be due to epitope-sharing of two unrelated molecules. Recently, we generated two newmonoclonal antibodies against recombinant smoothelin. The epitopes recognized by these monoclonal anti-bodies differed from the one reacting with R4A. However, they still recognized both isoforms (unpublished results). The two forms of smoothelin are not transcripts of two different genes. In situ hybridization on metaphase spreads showed that only hybridizing loci are found on both chromosomes 22 (Fig. 3 ). Southern blotting of genomic human DNAdigested with a variety of endonucleases and hybridized with the full size (for the visceral form) human CDNAof smoothelin, showed banding patterns as expected for a single copy gene (Fig. 3) . other SMCcomponents such as desmin, vimentin and tubulin (36) . Primary cultures of SMCof several humantissues, such as colon, arteria and uterus lost expression of smoothelin almost directly after culturing. Whether this was due to an immediate blockage of smoothelin gene transcription or selection of proliferative SMCduring the initial phase of culturing was unclear. However, presence of smoothelin was demonstrated to be maintained in primary cell culture of cells derived from a prostate epithelial cells. By immunohistochemical staining it was demonstrated that the cells contained desmin, smoothelin, vimentin and a-smooth muscle actin (Fig. 4) . The presence of the smoothelin and desmin protein could be demonstrated for four passages. The concentration of smoothelin and desmin was highest in the first passage and decreased gradualy during subsequent passages. Also the number of smoothelin positive cells decreased during the following passages. No changes were observed in the expression of asmooth muscle actin and vimentin which were also found in later (> 5) passages (data not shown). Smoothelin appeared to colocalize with or be attached to actin stress fibers. Smoothelin synthesis appeared to be main-tained in cells with a slender, spindle-like configuration, but was lost in cells showing a more rounded or square shape (Fig. 4) .
DISCUSSION
Smooth muscle cells differ from striated, skeletal and heart, muscle cells in structure, molecular composition and contractile characteristics. The contractile apparatus of SMC is differently organized. The contractile fibrils do not exhibit a sarcomeric repetitive structure, as in striated mucle cells. In conjunction with this difference a number of structural or associated proteins involved in the architecture of striated myofibrils, such as titin and nebulin, are not found in SMC,whereas other proteins such as metavinculin, SM22and calponin, are almost exclusively found in SMC (10, ll, 12) . It is expected that the differences in the structural organization of SMC(versus striated cells) will be reflected in differences of the proteins used for its construction.
Although a number of SMCspecific proteins have been identified and characterized, so far smoothelin and smooth muscle myosin heavy chain SMI and SM2appear to be the only proteins, exclusively expressed in (contractile) SMC (21, 36, 37) .
One of the obstructions in studying the localization and function of smoothelin and its interaction with other SMC components has been the lack of a cell culture system in which smoothelin expression was maintained. Only primary cell cultures from embryonic chicken gizzard were occasionally observed to continue smoothelin synthesis during the first passage (36) . The availability of primary cell cultures of cells derived from humanbenign prostate hyperplasia that reproducibly continue to synthesize smoothelin for a number of passages will accelerate the investigation into the localization and the dynamics of interaction with other proteins, and eventually will help to elucidate the function of smoothelin. The data presented here provide an example of the opportunities this system mayprovide.
The clear cytological colocalization of smoothelin with actin in these humancells confirms the results previously obtained with primary cell cultures from embryonic chicken gizzard (36) . However, the prostate system can also be used to study the fading of smoothelin in SMC over a numberof passages and its relation with contractility and organization of the contractile apparatus. In addition, this system provides opportunities to test promoter-deletion constructs of the smoothelin gene. The full implications of the occurence of a second (iso)form of smoothelin, that seems to be specific for vascular SMCare not clear yet. In the view of recent publications on SM22, dealing with distinct transcriptional regulatory programs in vascular and visceral SMC, this is an intriguing observation (20, 24 (3), Hindi (4) and BamHI (5). The filter has been hybridized to a [32P] labeled smoothelin CDNAfragment bp 1-600. The probe hybridized only to one or two fragments. B: In situ hybridization with a smoothelin cosmid probe. A signal is displayed in de chromosome spread (short arrows) as well as in the interphase nucleus (long arrow).
report the presence of 'heavy' smoothelin in the vascular tissues of rabbit, pig, dog and men. Wehrens and coworkers showed the presence 'heavy' smoothelin in chicken and demonstrated that the increase in molecular weight is not due to dimer formation or association with another SMCcomponent (Wehrens et al. in preparation) . The two forms of smoothelin may be a mere reflection of the embryonic origin of the SMC.SMCof the visceral and urogenital tissues are considered to be derived of cells of the mesodermal plate that migrate to form the linings of the tracts of organs such as gut, uterus and prostate (29). In these tissues the 59 kDa isoform of smoothelin is expressed. The origin of the SMC aligning the vascular system is still under debate although the hypothesis that these cells are recruited from the direct surroundings of the vessels under influence of factors produced by the endothelial cells, is now more widely accepted (15, 16) . In these cells the 94 kDa isoform of smoothelin is found. Four explanations can be given for the occurence of two forms of smoothelin: 1) two genes encode the two different forms; 2) alternative splicing maybe responsable for a longer form of the protein in the vascular tissue; 3) different transcriptional regulation (dual promotor) in vascular and visceral tissues; 4) differences in posttranslational modifications mayinfluence the apparent molecular weight of the molecules. The first possibility has been ruled out. In situ hybridization on metaphase spreads with a smoothelin cosmid probe did not show any reproducable signal in addition to the ones on chromosome22. This is more extensively described in an in situ hybridization study aimed at the assignment of the smoothelin gene to chromosome22 and its position on the chromosome (Engelen et al. , submitted). The FISH results corroborate those of the Southern blotting analysis revealing a banding pattern which is in agreement with smoothelin as a single copy gene in the humangenome. The choice between the other three alternatives will need moreexperimental evidence. However, considering the structure of the putative smoothelin deduced from the known CDNA sequence an extensive posttranslational modification, resulting in an apparent molecular weight Fig. 4 . Second passage of a primary culture of benign prostate hyperplasia cells immunohistochemically stained with rabbit desmin antiserum pDes (A), smoothelin monoclonal antibody R4A (B), and actin monoclonal antibody sm-1 (C). The staining pattern of R4A and sm-1 are similar and differ of the one displayed after incubation with desmin antiserum. Not all cells react. increase of more than 50%, seems to be unlikely. Therefore, future research will focus on the second and third alternative.
